Treosulfan
- Generic Name
- Treosulfan
- Brand Names
- Trecondi
- Drug Type
- Small Molecule
- Chemical Formula
- C6H14O8S2
- CAS Number
- 299-75-2
- Unique Ingredient Identifier
- CO61ER3EPI
Overview
Treosulfan is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Treosulfan has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
Background
Treosulfan is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Treosulfan has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
Indication
Not Available
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
TRECONDI POWDER FOR SOLUTION FOR INFUSION 1 G PER VIAL
Manufacturer:Oncotec Pharma Produktion GmbH
Form:INJECTION, POWDER, FOR SOLUTION
Strength:1 g / vial
Online:Yes
Approved: 2023/12/26
Approval:SIN16923P
TRECONDI POWDER FOR SOLUTION FOR INFUSION 5 G PER VIAL
Manufacturer:Oncotec Pharma Produktion GmbH
Form:INJECTION, POWDER, FOR SOLUTION
Strength:5 g / vial
Online:Yes
Approved: 2023/12/26
Approval:SIN16922P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath